However, because Nurr1 performs numerous roles, including protection of dopaminergic neurons against neurotoxins and regulating neuroinflammation, hence further studies are needed to validate Nurr1-based PD therapies (Kandil et al., 2018; Paliga et al., 2019). This evidence concerns the gene NR4A2 and Parkinson disease.